Appropriate selection of patients for 1st line monotherapy in advanced or unresectable HCC and treatment management in relation with AEs

Tuesday, November 23rd 2021
JST (+1 DAY)

About This Meeting

The HCC Virtual Experts Knowledge share will address “Appropriate selection of patients for 1st line monotherapy in advanced or unresectable HCC and treatment management in relation with AEs”. Chaired by Prof. Richard Finn, MD, (USA) and co-chaired by Dr Mohamed Bouattour (France) and James Harding, MD (USA).

The educational objectives for the meeting are:

  • Explore the patient-profile who could benefit from VEGFR-TKI monotherapy 1st line in advanced or unresectable HCC
  • Interpret the real-world data and understand the implications for clinical practice
  • Understand the safety profile of the monotherapies, be able to recognise the cause of toxicities and know the appropriate dosing strategies to manage side effects
  • A look into the future, the potential of combination therapies in the treatment of HCC

Meeting Materials

To view meeting materials, you need to be registered for the meeting.


Richard S Finn, MD
Gastrointestinal Medical Oncologist
Geffen School of Medicine at UCLA in the Department of Medicine Division of Hematology/Oncology, USA
Mohamed Bouattour, MD
Gastroenterologist, Hepatologist and Medical Oncologist
The University Beaujon Hospital Clichy, Beaujon , France
James J. Harding , MD
Gastrointestinal Oncologist
Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, USA
This HCC CONNECT programme is supported by Independent Educational Grant from Eisai Europe Limited

COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.
Bodenackerstrasse 17
4103 Bottmingen
Disclaimer: The material and content contained in the website is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved 
Website design & maintenance by Zesty Digital
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.